These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10882281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
    Liao R, Yang X, Wang S, Zhou Q, Nie Q, Zhong W, Dong S, Wu Y.
    Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):652-5. PubMed ID: 23164351
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS, Kim IJ, Kim SJ, Pak K, Kim K.
    Onkologie; 2011 Nov; 34(6):298-303. PubMed ID: 21625182
    [Abstract] [Full Text] [Related]

  • 5. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
    Gupta NC, Rogers JS, Graeber GM, Gregory JL, Waheed U, Mullet D, Atkins M.
    Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
    [Abstract] [Full Text] [Related]

  • 6. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
    Sun Y, Yu H, Ma J, Lu P.
    PLoS One; 2016 Dec; 11(8):e0161764. PubMed ID: 27560933
    [Abstract] [Full Text] [Related]

  • 7. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
    Yang MF, Tong ZH, Wang Z, Zhang YY, Xu LL, Wang XJ, Li W, Wu XZ, Wang W, Zhang YH, Jiang T, Shi HZ.
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
    [Abstract] [Full Text] [Related]

  • 8. [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
    Buchmann I, Guhlmann CA, Elsner K, Gfrörer W, Schirrmeister H, Kotzerke J, Buck A, Reske SN.
    Nuklearmedizin; 1999 Jul; 38(8):319-22. PubMed ID: 10615665
    [Abstract] [Full Text] [Related]

  • 9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
    Duysinx B, Nguyen D, Louis R, Cataldo D, Belhocine T, Bartsch P, Bury T.
    Chest; 2004 Feb; 125(2):489-93. PubMed ID: 14769729
    [Abstract] [Full Text] [Related]

  • 11. ¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation.
    Letovanec I, Allenbach G, Mihaescu A, Nicod Lalonde M, Schmidt S, Stupp R, Fitting JW, Boubaker A, Ris HB, Prior JO.
    Nuklearmedizin; 2012 Feb; 51(5):186-93. PubMed ID: 22584348
    [Abstract] [Full Text] [Related]

  • 12. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, Erginel S.
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [Abstract] [Full Text] [Related]

  • 13. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [Abstract] [Full Text] [Related]

  • 14. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
    Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ.
    Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S25-30. PubMed ID: 10536941
    [Abstract] [Full Text] [Related]

  • 15. Indeterminate pleural metastasis on contrast-enhanced chest CT in non-small cell lung cancer: improved differential diagnosis with (18)F-FDG PET/CT.
    Jung MY, Chong A, Seon HJ, Choi S, Kim YH, Shin SS, Kim JW, Bom HS.
    Ann Nucl Med; 2012 May; 26(4):327-36. PubMed ID: 22350956
    [Abstract] [Full Text] [Related]

  • 16. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
    Ryu JS, Choi NC, Fischman AJ, Lynch TJ, Mathisen DJ.
    Lung Cancer; 2002 Feb; 35(2):179-87. PubMed ID: 11804691
    [Abstract] [Full Text] [Related]

  • 17. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
    Kwek BH, Aquino SL, Fischman AJ.
    Chest; 2004 Jun; 125(6):2356-60. PubMed ID: 15189963
    [Abstract] [Full Text] [Related]

  • 18. A PET-CT score for discriminating malignant from benign pleural effusions.
    Simó M, Persiva O, Sánchez L, Montoro B, Vázquez A, Sansano I, Alemán C.
    Med Clin (Barc); 2023 Nov 24; 161(10):422-428. PubMed ID: 37487808
    [Abstract] [Full Text] [Related]

  • 19. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
    Porcel JM, Hernández P, Martínez-Alonso M, Bielsa S, Salud A.
    Chest; 2015 Feb 24; 147(2):502-512. PubMed ID: 25188411
    [Abstract] [Full Text] [Related]

  • 20. Atypical Layering of FDG in Pleural Effusion.
    Han EJ, Yoon H, Choi WH.
    Clin Nucl Med; 2024 Feb 01; 49(2):162-165. PubMed ID: 37976534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.